RxDoctor Payments Data

Gerard Guerin, DPM

Podiatrist · Biloxi, MSNPI 1629098660

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Smith+Nephew at 40.8% of the total. Reporting peaked in 2024 at $301 and has fallen 60.0% since, to $120 in 2025.

$1,117in general payments, 2019–2025

Across 24 payments — averaging $46.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$456
  • Mimedx Group, Inc.$305
  • Janssen Scientific Affairs, LLC$135
  • Organogenesis Inc.$123
  • Scilex Pharmaceuticals Inc.$73
  • Kerecis Limited$26

What the payments were for

  • Food & beverage$1,117100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,117 in reported general payments places this provider in the 65th percentile of 28 podiatrist providers in Mississippi.

See all podiatrist providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,185,663
Medicare patients
259
Services billed
2,984

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →